AMSilk Germany

Funding enables AMSilk to scale industrial production and meet global customer demand for biotech produced silk-based protein materials The financing round was led by existing investor ATHOS (AT Newtec), with strong participation from fellow existing investors MIG Capital and Novo HoldingsThe total EUR 52M includes EUR 30M in cash and EUR 22M in convertible equityView original content:https://www.prnewswire.co.uk/news-releases/amsilk-secures-eur-52m-strategic-financing-to-accelerate-commercial-growth-302549717.html